The Development of Peptide-based Antimicrobial Agents against Dengue Virus

Current Protein & Peptide Science
Yen-Wei HuangKeng-Shiang Huang

Abstract

Dengue fever has become an imminent threat to international public health because of global warming and climate change. The World Health Organization proclaimed that more than 50% of the world's population is at risk of dengue virus (DENV) infection. Therefore, developing a clinically approved vaccine and effective therapeutic remedy for treating dengue fever is imperative. Peptide drug development has become a novel pharmaceutical research field. This article reviews various peptidesbased antimicrobial agents targeting three pathways involved in the DENV lifecycle. Specifically, they are peptide vaccines from immunomodulation, peptide drugs that inhibit virus entry, and peptide drugs that interfere with viral replication. Many antiviral peptide studies against DENV have been conducted in animal model trials, and progression to clinical trials for these promising peptide drugs is anticipated.

Citations

Aug 24, 2018·Biomolecules·Fatma Gizem AvciElif Ozkirimli
Jan 4, 2019·Protein and Peptide Letters·Esteban N LorenzonEduardo M Cilli
Jun 20, 2020·Current Topics in Medicinal Chemistry·Anusuya ShanmugamM Michael Gromiha

❮ Previous
Next ❯

Methods Mentioned

BETA
phage-display

Software Mentioned

AVP
BioMoDroid

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

JAMA : the Journal of the American Medical Association
Howard Bauchner, Phil B Fontanarosa
Pakistan Journal of Pharmaceutical Sciences
Muhammad Imran QadirMuhammad Ali
International Journal of Medical Sciences
Miaw-Fang ChewChit-Laa Poh
© 2022 Meta ULC. All rights reserved